RT Journal Article
SR Electronic
T1 Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000878
DO 10.1136/jitc-2020-000878
VO 8
IS 1
A1 Paolo Antonio Ascierto
A1 Bernard A Fox
A1 Walter J Urba
A1 Ana Carrizosa Anderson
A1 Michael B Atkins
A1 Ernest C Borden
A1 Julie R Brahmer
A1 Lisa H Butterfield
A1 Alessandra Cesano
A1 Daniel S Chen
A1 Tanja D de Gruijl
A1 Robert O Dillman
A1 Charles G Drake
A1 Leisha A Emens
A1 Thomas F Gajewski
A1 James L Gulley
A1 F Stephen Hodi Jr
A1 Patrick Hwu
A1 David Kaufman
A1 Howard L Kaufman
A1 Michael T Lotze
A1 Douglas G McNeel
A1 Kim A Margolin
A1 Francesco M Marincola
A1 Michael J Mastrangelo
A1 Marcela V Maus
A1 David R Parkinson
A1 Pedro J Romero
A1 Paul M Sondel
A1 Stefani Spranger
A1 Mario Sznol
A1 George J Weiner
A1 Jon M Wigginton
A1 Jeffrey S Weber
YR 2020
UL http://jitc.bmj.com/content/8/1/e000878.abstract